Found: 22
Select item for more details and to access through your institution.
Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 11, p. 1853, doi. 10.1007/s00262-007-0340-1
- By:
- Publication type:
- Article
Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 4, p. 515, doi. 10.1007/s00262-006-0204-0
- By:
- Publication type:
- Article
Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 10, p. 532, doi. 10.1007/s00262-002-0313-3
- By:
- Publication type:
- Article
Randomized trial of adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 10, p. 539, doi. 10.1007/s00262-002-0315-1
- By:
- Publication type:
- Article
High-scale expansion of melanoma-reactive TIL by a polyclonal stimulus: predictability and relation with disease advancement.
- Published in:
- Cancer Immunology, Immunotherapy, 2001, v. 50, n. 3, p. 134, doi. 10.1007/PL00006683
- By:
- Publication type:
- Article
Frequency and relative fraction of tumor antigen-specific T cells among lymphocytes from melanoma-invaded lymph nodes.
- Published in:
- International Journal of Cancer, 1998, v. 78, n. 2, p. 209, doi. 10.1002/(SICI)1097-0215(19981005)78:2<209::AID-IJC15>3.0.CO;2-5
- By:
- Publication type:
- Article
PD‐L1 expression by tumor cell lines: A predictive marker in melanoma.
- Published in:
- Experimental Dermatology, 2018, v. 27, n. 6, p. 647, doi. 10.1111/exd.13526
- By:
- Publication type:
- Article
Comparative analysis of BRAF, NRAS and c- KIT mutation status between tumor tissues and autologous tumor cell-lines of stage III/ IV melanoma.
- Published in:
- Experimental Dermatology, 2015, v. 24, n. 1, p. 70, doi. 10.1111/exd.12584
- By:
- Publication type:
- Article
Absence of amplification of CD4+CD25<sup>high</sup> regulatory T cells during in vitro expansion of tumor-infiltrating lymphocytes in melanoma patients.
- Published in:
- Experimental Dermatology, 2008, v. 17, n. 5, p. 436, doi. 10.1111/j.1600-0625.2007.00681.x
- By:
- Publication type:
- Article
Tissue Biomarkers in Melanoma Patients Treated with TIL.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0048729
- By:
- Publication type:
- Article
Defective activations of STAT3 Ser727 and PKC isoforms lead to oncostatin M resistance in metastatic melanoma cells.
- Published in:
- Journal of Pathology, 2009, v. 217, n. 5, p. 665, doi. 10.1002/path.2490
- By:
- Publication type:
- Article
Value of large scale expansion of tumor infiltrating lymphocytes in a compartmentalised gas-permeable bag: interests for adoptive immunotherapy.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Effect of Indoleamine 2,3 Dioxygenase Inhibitor on the Cytotoxic Activity of Tumour-infiltrating Lymphocytes.
- Published in:
- Acta Dermato-Venereologica, 2019, v. 99, n. 12, p. 1186, doi. 10.2340/00015555-3285
- By:
- Publication type:
- Article
Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Tumor infiltrating lymphocytes as adjuvant treatment in stage III melanoma patients with only one invaded lymph node after complete resection: results from a multicentre, randomized clinical phase III trial.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 8, p. 1663, doi. 10.1007/s00262-020-02572-1
- By:
- Publication type:
- Article
Adoptive T cell therapy combined with intralesional administrations of TG1042 (adenovirus expressing interferon-γ) in metastatic melanoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 7, p. 805, doi. 10.1007/s00262-015-1691-7
- By:
- Publication type:
- Article
Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy.
- Published in:
- European Journal of Immunology, 2001, v. 31, n. 7, p. 2007, doi. 10.1002/1521-4141(200107)31:7<2007::AID-IMMU2007>3.0.CO;2-S
- By:
- Publication type:
- Article
Defective lymphokine production by most CD8.
- Published in:
- European Journal of Immunology, 1994, v. 24, n. 9, p. 1966, doi. 10.1002/eji.1830240905
- By:
- Publication type:
- Article
Specificity, T cell receptor diversity and activation requirements of CD4.
- Published in:
- European Journal of Immunology, 1992, v. 22, n. 7, p. 1795, doi. 10.1002/eji.1830220719
- By:
- Publication type:
- Article
Treatment of Metastatic Melanoma with Autologous Melan-A/Mart-1-Specific Cytotoxic T Lymphocyte Clones.
- Published in:
- Journal of Investigative Dermatology, 2009, v. 129, n. 12, p. 2835, doi. 10.1038/jid.2009.144
- By:
- Publication type:
- Article
Adoptive TIL transfer in the adjuvant setting for melanoma: long-term patient survival.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Adoptive TIL Transfer in the Adjuvant Setting for Melanoma: Long-Term Patient Survival.
- Published in:
- Journal of Immunology Research, 2014, p. 1, doi. 10.1155/2014/186212
- By:
- Publication type:
- Article